Darrin Smith - 10 Feb 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Signature
/s/ Michael Costa, as Attorney-in-Fact
Issuer symbol
SBRA
Transactions as of
10 Feb 2026
Net transactions value
-$178,421
Form type
4
Filing time
12 Feb 2026, 20:28:26 UTC
Previous filing
12 Jan 2026
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Darrin Executive VP, CIO & Secretary C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN /s/ Michael Costa, as Attorney-in-Fact 12 Feb 2026 0002104848

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBRA Common Stock Award $0 +5,483 +5.2% $0.000000 110,674 10 Feb 2026 Direct F1
transaction SBRA Common Stock Tax liability $56,052 -2,927 -2.6% $19.15 107,747 10 Feb 2026 Direct F2
transaction SBRA Common Stock Award $0 +14,088 +13% $0.000000 121,835 10 Feb 2026 Direct F3
transaction SBRA Common Stock Tax liability $122,368 -6,390 -5.2% $19.15 115,445 10 Feb 2026 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 1,152 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested and were settled immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025.
F2 Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of restricted stock units previously granted to the reporting person.
F3 Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on March 19, 2025, including 896 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of PSUs earned was 168.4% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2025 and ending December 31, 2025.
F4 Includes 32,708 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.